Issue 1/2022
Content (12 Articles)
Acknowledgement to Referees
A Systematic Review of Cost-Effectiveness Analyses for Hepatocellular Carcinoma Treatment
Sydney C. Yuen, Adaeze Q. Amaefule, Hannah H. Kim, Breanna-Verissa Owoo, Emily F. Gorman, T. Joseph Mattingly II
The Utility of Economic Measures to Quantify the Burden of Tinnitus in Affected Individuals: A Scoping Review
Elza Daoud, Charlotte Caimino, Michael A. Akeroyd, Arnaud J. Noreña , David M. Baguley
Cost-Effectiveness Analysis of the Treatment Strategies with or without Opioid Medications in Surgery-Eligible Patients with Osteoarthritis in Japan
Tomoyuki Takura, Akira Yuasa, Naohiro Yonemoto, Sven Demiya, Hiroyuki Matsuda, Nozomi Ebata, Koichi Fujii, Muneaki Ishijima
Cost-Effectiveness of Inotuzumab Ozogamicin Compared to Standard of Care Chemotherapy for Treating Relapsed or Refractory Acute Lymphoblastic Leukaemia Patients in Norway and Sweden
I. van Oostrum, T. A. Russell-Smith, M. Jakobsson, J. Torup Østby, B. Heeg
A Real-World Assessment of Outcomes, Health Resource Utilization, and Costs Associated with Cerebral Edema in US Patients with Large Hemispheric Infarction
Nicole Tsao, Qiang Hou, Shih-Yin Chen, Steven R. Messe
Continuous Monitoring of Respiratory Rate with Wearable Sensor in Patients Admitted to Hospital with Pneumonia Compared with Intermittent Nurse-Led Monitoring in the United Kingdom: A Cost-Utility Analysis
Mehdi Javanbakht, Maziar Moradi-Lakeh, Atefeh Mashayekhi, Jowan Atkinson
Cost Effectiveness of a Cultural Physical Activity Intervention to Reduce Blood Pressure Among Native Hawaiians with Hypertension
Ashley F. Railey, Clemma Muller, Carolyn Noonan, Maureen Schmitter-Edgecombe, Ka’imi Sinclair, Corin Kim, Mele Look, J. Keawe‘aimoku Kaholokula
Economic Model to Evaluate the Cost-Effectiveness of Second-Line Nilotinib Versus Dasatinib for the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (CML-CP) in Italy
Massimiliano Bonifacio, Vikalp Maheshwari, Diana Tran, Gianluca Agostoni, Kalitsa Filioussi, Ricardo Viana
Patient and Caregiver Health State Utilities in Tuberous Sclerosis Complex
Siu Hing Lo, Jade Marshall, Hanna Skrobanski, Andrew Lloyd
Economic Analysis of the CADScor System for Ruling Out Coronary Artery Disease in England
Mehdi Javanbakht, Atefeh Mashayekhi, Mohsen Rezaei Hemami, Michael Branagan-Harris, Eoin Moloney